In Re The Detention Of L.K.

471 P.3d 975
Court of Appeals of Washington·Decided September 1, 2020·No. 53377-4·Published·Cited by 22 cases

Opinion

Filed

Washington State

Court of Appeals

Division Two

September 1, 2020

IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON

DIVISION II

In the Matter of the Detention of No. 53377-4-II

L.K.

PUBLISHED OPINION

WORSWICK, J. — Former RCW 71.05.215 (2018) establishes an involuntarily committed person’s right to refuse antipsychotic medication and requires that the State attempt to obtain such a person’s informed consent to treatment. The State is not relieved of this obligation merely because a physician believes an attempt to obtain informed consent would be futile.

LK appeals a superior court order authorizing the involuntary administration of antipsychotic medications. LK argues that the State failed to attempt to obtain her informed consent as required by statute, thereby violating her right to due process and rendering the order authorizing the involuntary administration of antipsychotic medication unlawful. We agree, reverse the superior court’s order, and remand to the superior court to vacate the order authorizing involuntary administration of antipsychotic medication.

FACTS

LK was diagnosed with schizoaffective disorder, bipolar type, and has been hospitalized at Western State Hospital (WSH) six times, most recently in August 2017. In February 2019, while LK remained hospitalized, her psychiatrist at WSH, Dr. Nagavedu Raghunath, petitioned

for an order granting the involuntary treatment of LK with antipsychotic medication. Specifically, Dr. Raghunath sought to treat LK with new medications: “Risperidone by mouth and later, Risperidone Long Acting Injectable; Fluphenazine Intramuscular if oral Risperidone refused.” Clerk’s Papers (CP) at 48.

The day before the hearing on the petition, the State secured LK’s signature on a “twenty-

four hour medication notice.” CP at 53. This notice documents LK’s understanding that she may refuse her medications the day prior to the hearing. LK indicated on the form that she agreed “to remain under medication as prescribed.” CP at 53.

The following day, at the hearing on the petition, Dr. Raghunath testified that LK was experiencing significant delusions. Dr. Raghunath explained that LK had responded well to treatment with Clozaril in the past, but in January she refused to take it. In February, she stopped all medications and began decompensating.

Dr. Raghunath testified that he had neither prescribed nor discussed treatment with risperidone or fluphenazine with LK. Instead, Dr. Raghunath focused on LK’s previous resistance to treatment with Clozaril:

Her kind of reason for not taking medication can vary [sic] anything from Clozaril needed regular blood draws to see how she is reacting to that, whether she is developing any kind of side effects to that. But she said that she has no blood in her body to give, and so she doesn’t want to have that medication. Then she said that it makes her too drowsy. She is not able to get up in the morning . . . . Then she also said that it makes her too tired during the day. So—and of course, she also said that she doesn’t think she needs that medication because she has no mental illness.

Report of Proceedings (March 1, 2019) (RP) at 8. Dr. Raghunath acknowledged that “[n]o discussion has happened” with LK about the newly proposed treatment for which he sought authorization to involuntarily administer.

The superior court commissioner entered findings of fact and conclusions of law supporting an order authorizing involuntary treatment with antipsychotic medications. As to LK’s consent to treatment, the commissioner focused on Dr. Raghunath’s testimony about LK’s feelings toward treatment with Clozaril and found: “[LK] has refused to consent to treatment with antipsychotic medication for the following reasons[.] She says she does not have enough blood in her body, that it makes her tired and that she does not have a mental health disorder.” CP at 56. The commissioner concluded that LK may be involuntarily treated with the antipsychotic medication requested in the petition.

LK moved to revise the commissioner’s order. At a hearing before a superior court judge on the motion to revise, LK argued, in relevant part, that the State failed to attempt to obtain her informed consent to the proposed treatment. The superior court denied LK’s motion to revise. The superior court reasoned:

She’s not taking her medications. She’s refused medications for a variety of delusional beliefs. I think that an attempt to obtain informed consent from somebody who is actively psychotic, schizophrenic, threatening, abusive, disrobing, etc., is an exercise in futility. It’s not what I think the statute contemplated.

....

Informed consent also I think implies that the person has a degree of competency such that they can choose between an alternative course in a rational thought process, as opposed to a delusional belief system.

RP (March 22, 2019) at 20 (emphasis added).

LK appeals the superior court’s order denying her motion to revise the commissioner’s ruling.

ANALYSIS

LK argues that the superior court violated former RCW 71.05.215, former RCW 71.05.217 (2016), and her due process rights by affirming the order authorizing the involuntary administration of antipsychotic medications when the State had failed to attempt to obtain her informed consent. We agree.

I. LEGAL PRINCIPLES

A person “possesses a significant liberty interest in avoiding the unwanted administration of antipsychotic drugs under the Due Process Clause of the Fourteenth Amendment.” Washington v. Harper, 494 U.S. 210, 221-22, 110 S. Ct. 1028, 108 L. Ed. 2d 178 (1990). Moreover, an involuntarily committed person possesses a statutory right to refuse the administration of antipsychotic medication. Former RCW 71.05.215(1); former RCW 71.05.217(7).1 But the right to refuse medication is not absolute. Our Supreme Court has recognized certain State interests that are sufficiently compelling to justify overriding a patient’s objection to medical treatment, including the preservation of life, the protection of interests of innocent third parties, the prevention of suicide, and the maintenance of the ethical integrity of the medical profession. In re Det. of Schuoler, 106 Wn.2d 500, 508, 723 P.2d 1103 (1986).

1 Former RCW 71.05.215 and former RCW 71.05.217 are the statutes applicable to LK’s case. Both statutes were subsequently amended, most recently in 2020 by LAWS OF 2020, ch. 302, §§ 30, 31. The amendments have no substantive impact on our analysis or holding.

The Due Process Clause of the United States Constitution requires procedural safeguards to ensure a person’s interests are taken into account before authorizing involuntary medication. Harper, 494 U.S. at 233. In Harper, the United States Supreme Court held that a Washington Department of Corrections policy for the involuntary administration of antipsychotic drugs to inmates satisfied constitutional due process requirements. 494 U.S. at 236. The policy entitled an inmate who refused to take medication, which a psychiatrist determined necessary, to a hearing before a special committee consisting of a psychiatrist, a psychologist, and the associate superintendent of the special offender center. Harper, 494 U.S. at 215. The inmate also had additional procedural rights surrounding the hearing, including the right to be informed of the tentative diagnosis, the factual basis for the diagnosis, and why the staff believed the medication to be necessary. Harper, 494 U.S. at 216.

Free access — add to your briefcase to read the full text and ask questions with AI

In Re The Detention Of L.K., 471 P.3d 975 (Wash. Ct. App. 2020).

471 P.3d 975 (In Re The Detention Of L.K.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Detention Of F.a.
Court of Appeals of Washington, 2026
In Re The Detention Of H.h.
Court of Appeals of Washington, 2026
Detention of D.W.
Court of Appeals of Washington, 2025
Detention Of Z.B.-F.
Court of Appeals of Washington, 2024
Detention Of C.r.
Court of Appeals of Washington, 2024
Detention of C.F.
Court of Appeals of Washington, 2024
Detention Of G.h.
Court of Appeals of Washington, 2024
In Re The Detention Of: A.O.-A.
Court of Appeals of Washington, 2024
Detention of M.K.
Court of Appeals of Washington, 2023
In Re The Detention Of: J.d.
Court of Appeals of Washington, 2023
Detention Of S.m.
Court of Appeals of Washington, 2023
In Re The Detention Of A.N.
Court of Appeals of Washington, 2023
In Re The Detention Of: C.C.
Court of Appeals of Washington, 2023
In Re The Detention Of: B.r.
Court of Appeals of Washington, 2023
Sherwood Auburn Llc, V. Joel Pinzon, Et Ano.
Court of Appeals of Washington, 2022
In Re The Detention Of L.S.
Court of Appeals of Washington, 2022
In Re The Detention Of R.F.
Court of Appeals of Washington, 2022
In Re The Detention Of: A.c.
Court of Appeals of Washington, 2022
In Re The Detention Of: P.r.
492 P.3d 236 (Court of Appeals of Washington, 2021)
Detention Of E.c.
Court of Appeals of Washington, 2021